Company Announcements ALPCO announced in July a strategic account sales and distribution agreement with Cisbio US. In August, Meridian Bioscience named Catherine A. Sazdanoff, president of Sazdanoff Consulting, and John C. McIlwraith, managing director of Allos Ventures, to its Board. Eurogentec appointed MoBiTec as a distributor of its AnaSpec products, qPCR kits, oligonucleotides and other […]
Company Announcements The Wistar Institute and Rockland Immunochemicals announced in July a partnership for discovery and research, including value-added collaborative opportunities to advance work across the translational gap. Axiogenesis, a provider of tissue-specific human cell types, signed a sublicense agreement with GE Healthcare to use human IPSCs, enabling it to develop cellular assays and models […]
Company Announcements SIRION Biotech announced in June that it will open an office in the Boston, Massachusetts, area. Advanced Cell Diagnostics raised $22 million in Series C equity financing, led by Summit Partners. Hepregen announced a European comarketing agreement with SOLVO Biotechnology for its HepatoPac and HepatoMune kits. The Next Gen Consortium designated the nonprofit […]
The inability to reproduce experimental results is a problem gaining increasing attention. A recent paper (see IBO 6/15/15), reported that about half of the annual spending on preclinical research in the US is on irreproducible studies. Last month, a task force of the American Society of Cell Biology (ASCB) published a white paper on the […]
Company Announcements N-of-One signed a business partner agreement with Affymetrix in May to provide CNV analysis interpretation for Affymetrix OncoScan assay customers. KromaTiD announced a distribution agreement with Tokyo Future Style for Japan. Sigma-Aldrich entered into an agreement with XCell Science to launch genetically engineered human neural-differentiated cells and accompanying culture media for neurological disease […]
Stockholm, Sweden 7/1/15—Addtech Life Science has announced the acquisition of Finnish firm Fenno Medical through its Mediplast business for an undisclosed amount. Fenno provides medical equipment and consumables as well as laboratory products to the health care, academic and industry sectors. Fenno generates annual revenues of €20 million ($22 million = €0.89 = $1) and […]
Since its introduction in 2013, the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) 9 system for genome editing has exploded. Products for CRISPR/Cas9 range from plasmids and oligonucleotides to transgenic animals and screening services. According to Bioinformatics LLC’s report, “The Market for CRISPR/Cas9 Genome Editing Products,” published in May and based […]
Company Announcements Full-year 2014 sales for Horizon Discovery climbed 79.1% to £11.9 million ($19.5 million) (see IBO 4/15/15). Sales benefit-ed from acquisitions, as well as demand for genome-editing services and molecular diagnostic reagent products. Products and Services revenues jumped 39.4% and 151.6% to make up 29% and 60% of sales, respectively. Sales for the Leveraged […]
Company Announcements Half-year sales for Abcam rose 7.7%, 13.8% in constant currency, to £66.7 million ($107.6 million) (see IBO 3/31/15). Product sales grew 10.4%, 16.7% excluding currency, to £62.7 million ($101.2 million). Sales of core and RabMAb primary antibodies grew 13.3% and 19.4% excluding currency to make up 68% and 15% of Product revenue, respectively. […]
Company Announcements Empire Genomics announced in January the acquisition of ID Labs, a molecular diagnostics–reagent firm. StoneCalibre announced that its portfolio company, Anatrace, acquired Microlytic, a provider of solutions for soluble protein crystallization, in January. The companies partnered in 2014 to develop and commercialize Analytic, a brand targeted at membrane-protein researchers. Exiqon 2014 sales grew […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
